Hyperosmolar dextrose injection for Osgood-Schlatter disease: A prospective randomized double-blind study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220236

Enrollment

Registered

2016-01-12

Start date

2012-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osgood-Schlatter disease

Interventions

Intervention type:DRUG Name of intervention:Hyperosmolar dextrose Dose form / Japanese Medical Device Nomenclature:INJECTION Route of administration / Site of application:PERIARTICULAR Dose per admini

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Osgood-Schlatter disease diagnosed by physical findings

Exclusion criteria

Exclusion criteria: The patients with hearts disease, kidney disease and breathing problem The patients with diabetic disease

Design outcomes

Primary

Measure	Time frame
VISA score for final follow up	—

Secondary

Measure	Time frame
Blood flow using ultrasonography The rate of adverse effect	—

Countries

Japan

Contacts

Public ContactNakase Junsuke

Kanazawa University Hospital

nakase1007@yahoo.co.jp+81-76-265-2374

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026